Icariside II Ameliorates Endothelial Dysfunction by Regulating the MAPK Pathway via miR-126/SPRED1 in Diabetic Human Cavernous Endothelial Cells

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s166734